Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
Jérémie Botton, Rosemary Dray‐Spira, Bérangère Baricault, Jérôme Drouin, Marion Bertrand, Marie-Joëlle Jabagi, Alain Weill, Mahmoud Zureik
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)VaccinationConfidence intervalHazard ratioSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Randomized controlled trialInternal medicinePediatricsImmunologyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyViral gastroenteritis research and epidemiology